Articles

“He always mentioned how popular I was.”

Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

Goldman Sachs’ research illustrates that while the stock market is closer to a dangerous bubble than it was a few months ago, an overall assessment of risk indicators is not that alarming.

“I would like the money to grow.”

Williams is one of the most successful athletes to ever take part in tennis, but she’s also been steadily building her collection of properties for many years.

Acclaimed singer Alanis Morissette has proven that she can conquer not only the music charts, but also the real estate market.

The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.

South Korea’s once-hot Kospi index is headed for another day of sharp declines as the AI trade loses steam.

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.

U.S. stock-index futures fell Sunday, after a massive tech selloff on Friday interrupted Wall Street’s two-month rally, and after new developments threatened the fragile cease-fire in the Iran war.

Investors are suddenly dumping technology stocks and rotating into other areas — including health insurers, banks and retailers.

Only seven companies cited oil prices as a reason for cutting or not updating their profit outlooks for the year.